Literature DB >> 11842821

Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission.

Esmeralda T H Molenaar1, Alexandre E Voskuyl, Ben A C Dijkmans.   

Abstract

OBJECTIVE: To investigate the relationship between functional disability, disease activity and radiological damage in patients with rheumatoid arthritis (RA) in remission.
METHODS: One hundred and eighty-six patients with RA in remission or with low disease activity were studied. The following variables were assessed at one time point: joint count, visual analog scale for pain, functional disability, i.e., health assessment questionnaire (HAQ) score, radiological joint damage as assessed by radiographs of hands and feet and scored according the Sharp-van der Heijde method, and presence of comorbidity. Disease activity was expressed as the disease activity score (DAS). Correlations were calculated by Spearman's rho coefficient of correlation. In addition, variables associated with the score were analyzed by logistic regression.
RESULTS: The median HAQ score was 0.25 [interquartile (IQR) range 0-0.75] and the median DAS was 1.0 (IQR 0.7-1.5). Of the 186 RA patients included, 82% were in remission according to the DAS. The median joint damage as assessed by the Sharp-van der Heijde score was 21 (IQR 9-74). Functional disability was significantly correlated with pain (rho 0.48, p < 0.001), disease activity (rho 0.42; p < 0.001), disease duration (rho 0.39; p < 0.001), radiographic joint damage (rho 0.37; p < 0.001), and age (rho 0.19; p = 0.01). In a logistic regression model functional disability was independently related to presence of pain, disease activity, radiographic joint damage and disease duration in decreasing order of strength, but not to age. sex and co-morbidity.
CONCLUSION: Patients with RA who are in remission might experience minimal functional disability and radiographic joint damage. Functional disability in RA patients in remission is most strongly related to the presence of pain and in lesser extent to disease activity, radiographic joint damage, and disease duration.

Entities:  

Mesh:

Year:  2002        PMID: 11842821

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Authors:  M Boers; M T Nurmohamed; C J A Doelman; L R Lard; A C Verhoeven; A E Voskuyl; T W J Huizinga; R J van de Stadt; B A C Dijkmans; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.

Authors:  F C Breedveld; C Han; M Bala; D van der Heijde; D Baker; A F Kavanaugh; R N Maini; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

3.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

4.  Radiological damage in patients with rheumatoid arthritis on sustained remission.

Authors:  G Cohen; L Gossec; M Dougados; A Cantagrel; P Goupille; J P Daures; N Rincheval; B Combe
Journal:  Ann Rheum Dis       Date:  2006-08-25       Impact factor: 19.103

5.  Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.

Authors:  Fabio Massimo Perrotta; Antonia De Socio; Silvia Scriffignano; Ennio Lubrano
Journal:  Clin Rheumatol       Date:  2018-02-21       Impact factor: 2.980

6.  Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study.

Authors:  Lydia Abasolo; Jose Ivorra-Cortes; Leticia Leon; Juan A Jover; Benjamín Fernández-Gutiérrez; Luis Rodriguez-Rodriguez
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

7.  Is hand bone mineral density a marker for hand function in patients with established rheumatoid arthritis? The correlation among bone mineral density of the hand, radiological findings and hand function.

Authors:  Beril Dogu; Banu Kuran; Figen Yilmaz; Ahmet Usen; Hulya Sirzai
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 2.980

Review 8.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

9.  Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.

Authors:  L Gossec; M Dougados; P Goupille; A Cantagrel; J Sibilia; O Meyer; J Sany; J-P Daurès; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

10.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.